NO953569L - Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse - Google Patents

Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse

Info

Publication number
NO953569L
NO953569L NO953569A NO953569A NO953569L NO 953569 L NO953569 L NO 953569L NO 953569 A NO953569 A NO 953569A NO 953569 A NO953569 A NO 953569A NO 953569 L NO953569 L NO 953569L
Authority
NO
Norway
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
substituted ethers
Prior art date
Application number
NO953569A
Other languages
English (en)
Norwegian (no)
Other versions
NO953569D0 (no
Inventor
Thomas D Aicher
Seung Hoon Cheon
Jeffrey Nadelson
William Ronald James Simpson
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO953569D0 publication Critical patent/NO953569D0/no
Publication of NO953569L publication Critical patent/NO953569L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO953569A 1994-09-13 1995-09-11 Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse NO953569L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (2)

Publication Number Publication Date
NO953569D0 NO953569D0 (no) 1995-09-11
NO953569L true NO953569L (no) 1996-03-14

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953569A NO953569L (no) 1994-09-13 1995-09-11 Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse

Country Status (26)

Country Link
EP (1) EP0702015B1 (da)
JP (1) JPH08109183A (da)
KR (1) KR960010649A (da)
CN (1) CN1130186A (da)
AT (1) ATE158585T1 (da)
AU (1) AU3055295A (da)
BR (1) BR9504004A (da)
CA (1) CA2157950A1 (da)
CO (1) CO4410332A1 (da)
CZ (1) CZ229595A3 (da)
DE (1) DE69500758T2 (da)
DK (1) DK0702015T3 (da)
ES (1) ES2108550T3 (da)
FI (1) FI954257A7 (da)
GR (1) GR3025405T3 (da)
HU (1) HUT73432A (da)
IL (1) IL115235A0 (da)
MY (1) MY132008A (da)
NO (1) NO953569L (da)
NZ (1) NZ272976A (da)
PE (1) PE50296A1 (da)
PL (1) PL310372A1 (da)
SI (1) SI0702015T1 (da)
SK (1) SK111195A3 (da)
TR (1) TR199501115A2 (da)
ZA (1) ZA957699B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
HU224548B1 (hu) * 1993-04-07 2005-10-28 Taiho Pharmaceutical Co. Ltd. Tiazolidinszármazékok és ezeket tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra

Also Published As

Publication number Publication date
FI954257A7 (fi) 1996-03-14
PL310372A1 (en) 1996-03-18
DE69500758D1 (de) 1997-10-30
DK0702015T3 (da) 1998-01-12
BR9504004A (pt) 1996-09-24
MY132008A (en) 2007-09-28
TR199501115A2 (tr) 1996-06-21
SI0702015T1 (en) 1998-02-28
IL115235A0 (en) 1995-12-31
CA2157950A1 (en) 1996-03-14
AU3055295A (en) 1996-03-28
JPH08109183A (ja) 1996-04-30
PE50296A1 (es) 1996-12-05
DE69500758T2 (de) 1998-02-26
CN1130186A (zh) 1996-09-04
NZ272976A (en) 1996-09-25
SK111195A3 (en) 1997-06-04
CZ229595A3 (en) 1996-04-17
HUT73432A (en) 1996-07-29
ZA957699B (en) 1997-03-13
NO953569D0 (no) 1995-09-11
EP0702015B1 (en) 1997-09-24
HU9502663D0 (en) 1995-11-28
GR3025405T3 (en) 1998-02-27
ATE158585T1 (de) 1997-10-15
FI954257A0 (fi) 1995-09-11
CO4410332A1 (es) 1997-01-09
ES2108550T3 (es) 1997-12-16
EP0702015A1 (en) 1996-03-20
KR960010649A (ko) 1996-04-20

Similar Documents

Publication Publication Date Title
AU556307B2 (en) 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
DK15589A (da) Kemiske forbindelser
NO981628L (no) (Metylsulfonyl)fenyl-2-(5H)-furanoner som cox-2 inhibitorer
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
NO20080456L (no) Nye 2,4-dianilinopyrimidinderivater, fremstilling derav og deres anvendelse som medikamenter, farmasoytiske sammensetninger og, spesielt, som IKK inhibitorer
UA39166C2 (uk) Похідні n-гідроксисечовини, що є інгібіторами ліпоксигенази у ссавців, спосіб їх одержання і спосіб інгібування ліпоксигенази у ссавців
NO20091626L (no) MGLUR5-modulatorer
ATE51620T1 (de) 3-(4-piperidinyl)-1,2-benzisothiazole und deren derivate, verfahren zu ihrer herstellung und verwendung als arzneimittel.
ATE212343T1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
WO2001010894A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
JPS55108860A (en) Hydroxypropylltriazole*its manufacture and use as medicine
AU8163294A (en) Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
SE8505488L (sv) Isosilybinfri silibinin
GR71207B (da)
DK274980A (da) 1-alkadien-2,4-yl-2-hydroxymethyl-3,4,5-trihydroxypiperidiner fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemidler
EE200200326A (et) Asendatud homopiperidüülbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
JPS567799A (en) Novel pseudotrisaccharide* its manufacture and use as medicine
FI823433A0 (fi) 1-/3-(6-fluor-1,2-benzisoxazol-3-yl)propyl/-4-(substituerade) piperaziner och -piperidiner, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning som laekemedel
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
NO953569D0 (no) Bisyklisk oksazol- og tiazol substituerte etere, fremgangsmåte for deres fremstilling og farmasöytisk preparat inneholdende disse
DE3161400D1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
DE3774715D1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.